Once-daily glucocorticoid treatment improves QOL in patients with adrenal insufficiency


eMediNexus    02 January 2018

A study reported online December 8, 2017 in The Lancet Diabetes-Endocrinology suggests that a once-daily, modified-release glucocorticoid regimen may reduce the recurrent infections and metabolic effects that can occur with multiple daily doses in patients with adrenal insufficiency and improve their quality of life (QOL).

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.